Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Revenue: 2016-2025

Historic Revenue for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $209.4 million.

  • Collegium Pharmaceutical's Revenue rose 31.42% to $209.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $757.1 million, marking a year-over-year increase of 26.34%. This contributed to the annual value of $631.4 million for FY2024, which is 11.41% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Revenue of $209.4 million as of Q3 2025, which was up 11.36% from $188.0 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Revenue peaked at $209.4 million during Q3 2025, and registered a low of $27.4 million during Q4 2021.
  • In the last 3 years, Collegium Pharmaceutical's Revenue had a median value of $149.7 million in 2023 and averaged $161.2 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Revenue crashed by 64.13% in 2021 and then soared by 373.72% in 2022.
  • Collegium Pharmaceutical's Revenue (Quarterly) stood at $27.4 million in 2021, then soared by 373.72% to $129.6 million in 2022, then increased by 15.53% to $149.7 million in 2023, then increased by 21.51% to $181.9 million in 2024, then spiked by 31.42% to $209.4 million in 2025.
  • Its Revenue stands at $209.4 million for Q3 2025, versus $188.0 million for Q2 2025 and $177.8 million for Q1 2025.